FDA NDC Directory · JSON-LD · Markdown

Potassium Chloride

NDC 62037-710 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerActavis Pharma, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA075604
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsPOTASSIUM CHLORIDE (10 meq/1)
Marketing started20020410
Marketing ended20260630
Package count1

External sources

Source: openFDA. Public-domain (CC0).